Recent Headlines
Within Pharmaceuticals
Ember Group Consulting & Ember Group Search Bolsters Talent Acquisition Capabilities with Appointment of Taylor Morrison as VP of Talent & MD of Ember Group Search
Ember Group appoints Taylor Morrison as VP of Talent & Managing Director of Ember Group Search. With 20+ years of global talent acquisition experience, Taylor will lead the firm's talent acquisition function, focusing on identifying and retaining top talent to drive business growth and spark careers. - April 15, 2025 - Ember Group Consulting LLC
GENINVO Announces Its Latest Innovation – Confidential Information Scanner (CIS) Tool
GENINVO, a leading provider of life science technology solutions, is proud to announce the launch of its latest innovation – the Confidential Information Scanner (CIS) Tool. This tool is designed to help organizations identify publicly available company confidential information (CCI) across... - April 12, 2025 - GenInvo, Inc.
Devonics Automation (Booth #4413) to Participate in Automate 2025, May 12–15, in Detroit, Michigan, USA
Devonics Automation will showcase collaborative robot (cobot) solutions designed to meet growing automation demands at the most influential automation event in the Americas. - April 07, 2025 - Devonics Automation
Minus K Congratulates to the following winners of their 2024/2025 Educational Giveaway
Celebrating its’ tenth year of their U.S. Educational Giveaway, Minus K Technology has to-date granted over $100,000 of its superior performing patented Negative-Stiffness low-frequency passive mechanical vibration isolators to colleges and universities in the USA. - April 03, 2025 - Minus K Technology Inc.
Wallflower Cannabis House Announces Second Location in Inspirada, Henderson
Wallflower Cannabis House, a renowned dispensary for Las Vegas locals, is thrilled to announce the opening of its second location on April 4 at 8am in the Inspirada area of Henderson, at 3485 Volunteer Blvd. Building on the success of its original location on Blue Diamond Road since 2020,... - April 02, 2025 - Wallflower Cannabis House
Apeximmune Therapeutics Announces Successful Close of Series A Fundraising Round to Advance Next-Generation Immunotherapies
Apeximmune Therapeutics, a biotechnology company pioneering next-generation immunotherapies, today announced the successful close of its Series A financing round, raising $21.3 million, exceeding its original goal of $20 million. The funding was led by PharmaEssentia Corporation, with participation... - April 01, 2025 - Apeximmune Therapeutics
Huntington Study Group Announces Executive Director of Clinical Operations
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to introduce Carolyn Schultz-Walter as the Executive Director of Clinical Operations. With over 25 years of global clinical operations experience spanning both sponsor and clinical research... - March 31, 2025 - Huntington Study Group
BlueCallom Launches COMPLY-AI, Challenging the $36 Billion Industry with a New AI Solution
BlueCallom today announced the launch of COMPLY-AI, an autonomous compliance management solution designed to support enterprise teams in meeting evolving regulatory requirements. COMPLY-AI offers an integrated platform that delivers self-service compliance assessments, saving over 2,000 expert hours annually. It also reduces operational delays and improves the time-to-market. - March 29, 2025 - BlueCallom AG
Dr. Mike Chan: Leading the Future of Organ-Specific Stem Cell Therapies with Revolutionary Treatments in Regenerative Medicine
Dr. Mike Chan is a global leader in regenerative medicine, transforming lives with stem cells, exosomes, and peptides. His innovative treatments regenerate tissues, restore healing, and enhance vitality. Patients experience renewed hope, improved energy, and recovery from chronic conditions. His groundbreaking work is reshaping the future of healthcare. - March 28, 2025 - Dr. Mike Chan
Carl Wittwer, MD, PhD, Joins PathogenDx’s Board of Advisors
Carl Wittwer, MD PhD, Professor Emeritus of Pathology at the University of Utah, a Co-Founder of Idaho Technologies/Biofire and previously spent 35+ years as a Medical Director at ARUP Laboratories is joining PathogenDx as Technology & Scientific Board Advisor to help advance its D3 Array technology in terms of Speed, Cost and Performance. - March 25, 2025 - PathogenDx, Inc.
Thar Process and Clean Heat Technologies Integrate CO2 Heat Pump Technology to Make Supercritical CO2 Technology a Low Cost Solution
Thar Process and Clean Heat Technologies have successfully engineered, integrated and installed electric heat pumps using CO2 - R744 - as the upcycled, natural refrigerant. The technology partnership means that Thar Process' clients can benefit from lower operating costs. Thar is known for it's innovative use of CO2 for extracting flavors, fragrances, medicinal and therapeutic compounds both in it's GMP certified facility in Pittsburgh and at client sites globally. - March 24, 2025 - Thar Process
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of hard-to-treat cancers. In combination with standard-of-care chemotherapy, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, prevents cancer recurrence, improves complete response rate and survival in experimental pancreatic cancer. In combination with anti-PD-L1 treatment, it overcomes pancreatic cancer resistance to immunotherapy. - March 21, 2025 - SignaBlok, Inc.
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug at the Respiratory Innovation Summit and American Thoracic Society International Conference 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of sepsis and pulmonary diseases. In experimental sepsis, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, protects from death with the level of protection not declining at delayed treatment times. In pulmonary inflammation and fibrosis in rats and mice, it reduces neutrophil infiltration in the lungs and reverses fibrosis. - March 21, 2025 - SignaBlok, Inc.
Addressing the Growing Crisis in Pain Management Medication Access
PMC Pharmacy Advocates for Transparent, Collaborative Solutions to Reduce Risk and Ensure Patient Care - A Path Forward for Pain Management Medication Access - March 19, 2025 - PMC Pharmacy
ALS Therapy Development Institute Joins DataCite to Expand Access and Impact of ARC Dataset
The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the... - March 18, 2025 - ALS Therapy Development Institute
Samantha's Outings Celebrates a Year of Empowerment and Community Engagement for Individuals with Autism
What Samantha's Outings has done in one year and where they will go in the future. - March 17, 2025 - Samantha's Outings
ConductScience Accepted Into NVIDIA Connect Program, Advancing AI-Driven Behavioral Neuroscience Research Solutions
ConductScience joins the NVIDIA Connect program, accelerating AI advancements in behavioral research. This collaboration enhances ConductVision, ConductInsecta, ConductNest, and GaitMaster, optimizing research on locomotion, cognition, and social behavior across species. With NVIDIA’s support, ConductScience gains access to GPU-accelerated computing, engineering resources, and training, driving innovation in neuroscience, genetics, and medicine. - March 16, 2025 - ConductScience
Trailhead Biosystems® Develops iPSC-Derived Vascular Leptomeningeal Cells
Trailhead Biosystems, Inc. announces the launch of TrailBio® Vascular Leptomeningeal Cells. - March 12, 2025 - Trailhead Biosystems, Inc.
BlueCallom Launches AgenticBlue: Transforming AI from a Shadowy Sidekick to a Mission-Critical Enterprise Investment
BlueCallom, a pioneer in Agentic AI Business Solutions, announced the launch of AgenticBlue, its a breakthrough Enterprise AI Management Platform. Designed to manage all unsupervised AI properties such as Prompts, Agents, and Multi-Agent solutions into strategically aligned, mission-critical investments. Those AI assets already represent a significant value. - March 12, 2025 - BlueCallom AG
eg technology Bolsters Global Presence with Appointment of Paul Anglim
eg technology Ltd. make key appointment as Paul Anglim joins the specialist product design, engineering and development consultancy as they continue their international expansion. - March 11, 2025 - eg technology Ltd
West Bengal Chemical Industries Limited Introduces Liposomal Skincare Technology
Liposomal technology, an advance technology, involves encapsulating active ingredients within lipid bilayers. - March 11, 2025 - West Bengal Chemical Industries Limited
New Bonus Modules for the Certificate GMP Training
Pharma Lessons has added two new bonus modules to the popular Good Manufacturing Practice Training. The new modules are already available to all currently enrolled users. The first module covers the major differences between the FDA and EMA GMP guidelines. And the second module is based on the GMP... - March 09, 2025 - Pharma Lessons
Cenmed and ENG Scientific Partner to Deliver High-Quality Kitting and Custom Chemical Filling Solutions
Cenmed Enterprises and ENG Scientific have expanded their partnership to enhance kitting and custom chemical filling services for laboratories, biotech companies, and healthcare institutions. By combining Cenmed’s supply chain expertise with ENG’s chemical formulation capabilities, the collaboration streamlines reagent kit production, specimen collection solutions, and bulk chemical filling. This partnership strengthens Cenmed’s ability to deliver efficient, compliant, and scalable solutions. - March 07, 2025 - Cenmed
HistAI Unveils Groundbreaking SPIDER Initiative at HIMSS Conference
At the HIMSS Conference, HistAI announced the SPIDER Initiative, an open-source project set to become the largest supervised medical imaging dataset. The initiative will compile more than 50 millions of fully annotated images from 20 organs and 400 morphologies, advancing AI-driven diagnostics, precision medicine, and drug development. The first release includes more than 4 millions of images from 6K Whole Slide Images (WSIs) across Skin, Colorectal, and Thorax. Available starting today. - March 06, 2025 - HistAI
matrihealth GmbH Qualifies Soluble Elastin Hydrolysate matripure® for Use in Cosmetics
matrihealth GmbH has qualified matripure® elastin for use in cosmetics, providing manufacturers with a high-quality raw material made in Germany. - March 06, 2025 - matrihealth GmbH
Regenexx® Corporate Program's Dr. Mark Testa Wins the YOU Powered Symposium 2025 Most Influential Clinician in Insurance Award
The YOU Powered Symposium is the leading annual event for "bold benefits trailblazers." It brings together hundreds of benefit professionals, solution providers, clinicians, and employers to combine diverse expertise in an effort to reform the US healthcare system on behalf of every patient. - March 04, 2025 - Regenexx Corporate Program
AI MINDSystems Foundation and GenoBank.io Announce Strategic Partnership at ETHDenver to Advance Decentralized Biobanking and Healthcare Innovation
AI MINDSystems and GenoBank.io partner at ETHDenver to advance decentralized biobanking. Integrating GenoBank.io’s BioNFT™ into the AI MINDSystems Trusted Data Ecosystem™ empowers individuals with control over their biosamples via ‘lockable’ NFTs. This collaboration aims to create secure, privacy-preserving solutions for digital biology, precision health, and research, using blockchain and Web3 technologies. They also plan to launch WISDOM Networks™ for data-driven healthcare transformation. - February 28, 2025 - AI MINDSystems Foundation
Trump-Era Administration Drug Development & Outsourcing Impact Report
How Tariffs and RFK Jr.’s HHS Appointment May Shift Drug Development & Outsourcing - February 27, 2025 - Life Science Strategy Group, LLC
Purity Health, LLC Announces Lora Harnack as New Chief Executive Officer
Purity Health, LLC has appointed Lora Harnack as its new Chief Executive Officer, with former CEO Rob Bramblett transitioning to President. Harnack, a Tennessee native with 30 years of healthcare leadership experience, has held executive roles in hospital administration, healthcare IT, and nonprofit organizations, most recently leading the Cumberland Pediatric Foundation. - February 21, 2025 - Purity Health, LLC
PathogenDx Launches Its Rebranded D3 Array™ Combined, Bacterial and Fungal Assays—Delivering Value in Turn-Around Time, Cost and Throughput to Testing Labs
PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of its new rebranded D3 Array™ Combined, Bacterial and Fungal assays to replace Detectx–Combined,Detectx-Bacterial and Detectx-Fungal tests. - February 20, 2025 - PathogenDx, Inc.
Two Peoria Residents Win $20,000 in National Transformation Contest
Wayne Galpin and Kaitlyn Willis of FXB Peoria have won the 2024 Farrell’s National Challenge, each earning $10,000 for their remarkable yearlong fitness transformations. Farrell’s eXtreme Bodyshaping (FXB) combines kickboxing, strength training, nutrition coaching, and accountability to help members achieve lasting health results. Their dedication not only transformed their lives but also inspired their community. - February 19, 2025 - Farrell's Extreme Body Shaping
New Book "Messy Mind, Brilliant Life" Empowers ADHD Individuals to Thrive; Dr. Heather Wisdom’s Guide to Unlocking the Power of the ADHD Brain
Author and podcast host Dr. Heather Wisdom announces the release of Messy Mind, Brilliant Life: A Practical Guide to Thriving with ADD/ADHD. This book reframes ADHD as a unique way of thinking rather than a deficit and offers strategies for harnessing its strengths. - February 19, 2025 - Dr. Heather Wisdom
Health Response Alliance Launched to Unify Disaster Response Efforts Across Sectors
Health Response Alliance (HRA) unites public, private, and nonprofit partners to strengthen disaster response. Led by CEO Tom Cotter, HRA streamlines resource-sharing and coordination, emphasizing cross-sector collaboration and early-stage crisis intervention. With evolving federal policies, HRA fills gaps by fostering cooperation among health agencies and other key stakeholders, ensuring communities receive timely, equitable, and effective support during emergencies. - February 19, 2025 - Health Response Alliance
Young Adults with Special Needs Face Critical Gap in Support Services; Samantha's Outings Provides Vital Community Resource
There's a void in aid once children with special needs become adults, Samantha's Outings aims to fill that void. - February 18, 2025 - Samantha's Outings
NuvOx Announces MHRA Approval to Commence Phase IIb Stroke Trial
NuvOx Therapeutics, Inc. (“NuvOx”) announced that The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom in collaboration with the Research Ethics Committee has accepted the amended request for a clinical trial authorisation (CTA). This acceptance will... - February 14, 2025 - NuvOx Therapeutics
Tricerat Names New CEO and Launches New ScrewDrivers® for Next-Gen Print Management
Tricerat, the industry-leading print management software since 1997, appoints Hannah Shuman as President & CEO. New leadership also comes with a new product: ScrewDrivers® 7.8.0 adds more granular permissions, ARM64 compatibility, and expanded support for secure printing in complex desktop, VDI, cloud, and hybrid setups. - February 12, 2025 - Tricerat
Biovenic Scripts a New Chapter to Boom Veterinary Diagnostics
Biovenic, a powerhouse in veterinary research, transforms the way to detect and manage animal diseases, spotlighting innovative animal disease diagnostic solutions that answer the rising demand for exact and precise veterinary diagnostics worldwide. - February 12, 2025 - Biovenic
expEDIum Announces the Launch of expEDIum Office EHR
expEDIum announces the Q2 2025 launch of expEDIum Office EHR, a gastroenterology-focused EHR designed to streamline workflows, enhance patient care, and ensure compliance with industry standards. - February 08, 2025 - expEDIum
Legacy Pharma Inc. SEZC Announces the Acquisition of InterMune, Inc. and the U.S. Rights to Esbriet® from Genentech a Member of the Roche Group
Legacy Pharma Inc. SEZC (“Legacy Pharma” or the “Company”), a specialty pharmaceutical company, announced the completion of the acquisition of InterMune, Inc. (“InterMune”) and the intellectual property rights to Esbriet® (pirfenidone) in the United States... - February 06, 2025 - Legacy Pharma Inc. SEZC
Solution Group Partners with 424 Capital to Accelerate Growth and Expand Service Offering
Solution Group, a leading provider of water and wastewater services, consulting, and technology announced today that it has secured a strategic investment from 424 Capital to accelerate growth and expand its service offering. This partnership marks a significant milestone in Solution Group’s history, allowing the Company to continue its recent growth and provide additional value to clients. - February 03, 2025 - Solution Group
Rajesh (Raj) B. Shah Joins CR&T Board of Directors to Advance Cancer Research and Treatment
The Cancer Research & Treatment Fund, Inc. (CR&T) proudly announces the appointment of Rajesh (Raj) B. Shah to its esteemed Board of Directors. Raj brings a wealth of experience and passion to CR&T’s mission of advancing the fight against cancer. His appointment reinforces the... - January 29, 2025 - The Cancer Research & Treatment Fund, Inc.
Hemanext Announces Close of Series B-2 Equity Funding Round
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces close of series B-2 equity fundraising round. The B-2 fundraising was launched in May 2024 to raise $16-20 million and was completed in October 2024, raising just over $20 million at a pre-money... - January 27, 2025 - Hemanext
African Mission Healthcare Awards Dr. Gregory Sund the $500,000 L'Chaim Prize Which Will Improve Rural Healthcare for Women and Children in Africa
African Mission Healthcare is privileged to announce Dr. Gregory Sund, MD, FCA, as the recipient of the Gerson L'Chaim Prize for Outstanding Christian Medical Service. This prestigious $500,000 award, the largest annual award dedicated to direct medical care, is granted to Dr. Sund and his institution to implement a transformative proposal aimed at enhancing anesthesia care in East Africa. The project will focus on safe anesthesia, benefiting women and children's health in under-resourced areas. - January 22, 2025 - African Mission Healthcare
DDi Released New ViSU eIFU Version for Medical Device Companies
DDi has launched an updated version of its ViSU eIFU platform, designed for medical device manufacturers to transition from traditional paper instructions to electronic formats. The platform supports regulatory compliance with global standards, including the EU MDR and FDA, while providing multi-language accessibility and an enhanced user experience. - January 17, 2025 - DDi LLC
Purple Diamond Hosting Exclusive Webinar on Pharmaceutical Packaging Validation and Product Integrity
Purple Diamond, a leading ISO-accredited package testing lab, will host a free webinar on February 4, at 2 pm EST. "Protecting Pharma Integrity: The Science of Packaging Validation" will provide insights into testing methodologies and tools critical for ensuring pharmaceutical packaging safety and compliance. - January 16, 2025 - Purple Diamond Testing
Bench International Celebrates 50 Years of Transforming Life Sciences Leadership
Bench International, the longest-serving woman-founded executive search firm in life sciences, is proud to celebrate its 50th Anniversary, marking five decades of shaping transformative leadership in the industry. This milestone will be commemorated at a special gala event next week in San... - January 10, 2025 - Bench International
Operation Dream Landing Launches: Empowering Undecided with Industry Awareness and Dream Career Pathways
Dream2Career today announced the launch of Operation Dream Landing, a collaborative media project designed to empower undecided students and career seekers with the reliable information and resources they need to define their pathway to success. Dream2Career is actively seeking experts to join this unified talent marketing project. - January 10, 2025 - Dream2Career
Conigen Bioscience and North Star Scientific, Inc. Partner to Broaden Access to Next-Generation Dimeric-Specific Epitope Tool-Molecules, Empowering Drug Discovery
Conigen Bioscience, Inc., based in Worcester, Massachusetts, has partnered with North Star Scientific, Inc. to expand access to its transformative protein tools across North America. Conigen pioneers innovations in bioactive conformational soluble dimer proteins and membrane proteins displayed on... - January 07, 2025 - Conigen Bioscience, Inc
Physicians Research Group and bioaccess® Join Forces to Expand Clinical Trial Opportunities in South America
Physicians Research Group (PRG), a leading clinical trial site network and bioaccess®, Latin America’s premier contract research organization (CRO), are proud to announce a strategic collaboration aimed at advancing clinical research and increasing access to innovative treatments across South America. - January 07, 2025 - Physicians Research Group
Ales for ALS Achieves $1 Million Milestone and Expands Nationwide
Ales for ALS™, a global initiative uniting craft breweries in the fight against ALS, has reached an extraordinary milestone in 2024: raising $1 million in a single year. Supported by Yakima Chief Hops, this program has seen remarkable growth over its 13-year journey, fueled by the dedication of brewers, sponsors, and a passionate community. - January 06, 2025 - ALS Therapy Development Institute